SLC22A1-ABCB1 haplotype profiles predict imatinib pharmacokinetics in Asian patients with chronic myeloid leukemia.
about
Pharmacogenetics of BCR/ABL Inhibitors in Chronic Myeloid LeukemiaGenotypes of SLC22A4 and SLC22A5 regulatory loci are predictive of the response of chronic myeloid leukemia patients to imatinib treatment.ABCB1 genetic variants in leukemias: current insights into treatment outcomesGenetic factors affecting drug disposition in Asian cancer patients.Multidrug resistance gene 1 C1236T polymorphism and susceptibility to leukemia: A meta-analysisEuropean Treatment and Outcome Study score does not predict imatinib treatment response and outcome in chronic myeloid leukemia patientsABCB1 C3435T polymorphism is associated with leukemia susceptibility: evidence from a meta-analysisAssociation of ABCB1 and FLT3 Polymorphisms with Toxicities and Survival in Asian Patients Receiving Sunitinib for Renal Cell Carcinoma.CYP2C8 Genotype Significantly Alters Imatinib Metabolism in Chronic Myeloid Leukaemia Patients.The Impacts of SLC22A1 rs594709 and SLC47A1 rs2289669 Polymorphisms on Metformin Therapeutic Efficacy in Chinese Type 2 Diabetes Patients.Prognostic and predictive implications of Sokal, Euro and EUTOS scores in chronic myeloid leukaemia in the imatinib era-experience from a tertiary oncology centre in Southern India.Clinical relevance of pharmacogenetics in gastrointestinal stromal tumor treatment in the era of personalized therapy.OCT1 and imatinib transport in CML: is it clinically relevant?Role of SLC22A1 polymorphic variants in drug disposition, therapeutic responses, and drug-drug interactions.OCT1 genetic variants are associated with postoperative morphine-related adverse effects in children.hOCT1 gene expression predict for optimal response to Imatinib in Tunisian patients with chronic myeloid leukemia.Association of the hOCT1/ABCB1 genotype with efficacy and tolerability of imatinib in patients affected by chronic myeloid leukemia.Pregnane X receptor, constitutive androstane receptor and hepatocyte nuclear factors as emerging players in cancer precision medicine.Pharmacogenetics of drug transporters in modulating imatinib disposition and treatment outcomes in chronic myeloid leukemia & gastrointestinal stromal tumor patients.Pharmacogenetics and Pharmacogenomics of Targeted Therapeutics in Chronic Myeloid Leukemia.Whole Exome Sequencing of Chronic Myeloid Leukemia PatientsTrough concentration and ABCG2 polymorphism are better to predict imatinib response in chronic myeloid leukemia: a meta-analysis.A common novel splice variant of SLC22A1 (OCT1) is associated with impaired responses to imatinib in patients with chronic myeloid leukaemia.
P2860
Q26781539-E0FCD517-EDE0-41C9-99E9-258E5B84523DQ33577088-79F332A4-BA09-4B5B-B2AE-F00E3EC5F116Q33707782-534D8ABC-8A59-420C-8A55-89A51698B7C0Q34501025-C4E10096-CE8D-4CED-9924-6563BE18DF6FQ34607510-143A5B33-EB9A-4F52-ACA1-703BF6BC3DCDQ35051720-83DEFAFC-8D7E-4B0C-B9C5-FE67DCF132C4Q35593505-887E1CFD-B5F6-492F-A6BA-BF97F5D8D94CQ35921573-F8EAEB66-9AAE-4D6A-B501-7B9ED53AEE2EQ36229161-9F7B51E9-A76A-43C6-9B49-62DCE0273FDAQ36610479-3A6EF2B7-7ABB-4A0F-8061-DD748781AD69Q37404680-A6B13949-E194-441D-8DE4-25383DD8E1F9Q38112821-25E556D2-F9EC-46FD-B520-03DF356C0812Q38540022-EF6471AD-9AFA-481B-BE74-93AD59B90D7FQ38622785-7C1CB4B1-1475-4D30-87BE-CFF4DAA248CFQ38805917-681DACC1-2DA8-48B0-A371-1946B4E4A829Q38902116-945DAF75-D853-4515-8E6A-B0E5D5F90F31Q38910072-94CBD13C-3877-4EC0-BE17-F02DC8B9F495Q38937177-01DFA8FF-7CEF-4E78-AE87-C7ABEEE2C06DQ38996487-647D4FE9-6B04-4234-ABD7-8A53BE5157EDQ39429836-447722CC-FDE0-4B17-AA8E-61F0CB1D19CCQ40834039-7F3DFDFD-10B3-4FB7-B744-4587F291B6FAQ51251518-81F9450A-5D18-47DB-97FB-2306A97D6BD3Q54240000-A0E985F8-405F-4DFD-AF0B-4FA2C8EB1F03
P2860
SLC22A1-ABCB1 haplotype profiles predict imatinib pharmacokinetics in Asian patients with chronic myeloid leukemia.
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
SLC22A1-ABCB1 haplotype profil ...... with chronic myeloid leukemia.
@ast
SLC22A1-ABCB1 haplotype profil ...... with chronic myeloid leukemia.
@en
SLC22A1-ABCB1 haplotype profil ...... with chronic myeloid leukemia.
@nl
type
label
SLC22A1-ABCB1 haplotype profil ...... with chronic myeloid leukemia.
@ast
SLC22A1-ABCB1 haplotype profil ...... with chronic myeloid leukemia.
@en
SLC22A1-ABCB1 haplotype profil ...... with chronic myeloid leukemia.
@nl
prefLabel
SLC22A1-ABCB1 haplotype profil ...... with chronic myeloid leukemia.
@ast
SLC22A1-ABCB1 haplotype profil ...... with chronic myeloid leukemia.
@en
SLC22A1-ABCB1 haplotype profil ...... with chronic myeloid leukemia.
@nl
P2093
P2860
P1433
P1476
SLC22A1-ABCB1 haplotype profil ...... with chronic myeloid leukemia.
@en
P2093
Balram Chowbay
Charles Chuah Thuan Heng
Jason Yongsheng Chan
Keegan Lin
Onkar Singh
P2860
P304
P356
10.1371/JOURNAL.PONE.0051771
P407
P577
2012-12-18T00:00:00Z